Clinical trial
Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
NCT01999738
Study timeline
Study start (actual)2013-10-01Date precision: month
Registry last updated2019-02-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Solid Tumorsunresolved
Non Small Cell Lung Carcinomaunresolved
Interventions
EC1456 and EC20DRUG
Sponsors & collaborators
Endocytelead sponsor
Mapped research locations
HoustonTexas, United States2New YorkNew York, United States1ChicagoIllinois, United States1BaltimoreMaryland, United States1ClevelandOhio, United States1IndianapolisIndiana, United States1PhoenixArizona, United States1DetroitMichigan, United States1TucsonArizona, United States1BuffaloNew York, United States1ScottsdaleArizona, United States1DuarteCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01999738 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.